Skip to main content
. 2020 Sep 4;10:1697. doi: 10.3389/fonc.2020.01697

Figure 2.

Figure 2

Comparisons of serum EpCAM, TGM2, IL-33, CA-125, and HE4 levels in the healthy, benign, and endometrial cancer (EC) group. (A) EpCAM. (B) TGM2. (C) IL-33. (D) CA-125. (E) HE4. ***p < 0.001, **p < 0.01.